Roundup: Alnylam Launches Symptom Tracker App for Rare Diseases, UK Startup Raises £ 1.2million for Mental Fitness Platform, More Memories

ByLance T. Lee

Oct 22, 2021

New EU guidance on the classification of medical devices

New guidance on the classification of medical devices in the European Union (EU) has been published by the Medical Devices Coordination Group (MDCG). This group is made up of representatives of all Member States and chaired by a representative of the European Commission.

The document details how to classify medical devices, provides rules to inform the process, and describes the impacts of classification on pre- and post-market regulation.

Vodafone and Deloitte team up to launch e-health center

Vodafone and Deloitte team up to accelerate digital healthcare adoption through the Vodafone Center for Health online.

The virtual center aims to simplify access to care and connected solutions for patients and healthcare professionals.

Richard Houston, CEO of Deloitte Northern & Southern Europe, said: “Over the next two decades, healthcare as we know it will be completely transformed, with digital and connected healthcare solutions delivering new and more effective ways to diagnose, treat and support patients. Deloitte and Vodafone will be at the heart of this – working together to do it at scale, using our digital skills to transform the delivery of healthcare for all. “

Alnylam launches symptom tracking app for rare diseases

Alnylam Pharmaceuticals has launched a digital symptom tracker to help people in the UK with ATTR amyloidosis, a rare disease.

The STAR app allows patients to record their symptoms and share information with their doctor during or between visits.

Professor Philip Hawkins, Professor of Medicine at the National Amyloidosis Center, UK, said: “ATTR amyloidosis is a rapidly progressive multisystem disease characterized by increasing complexity and severity of symptoms. Because the disease can progress over time, it is important for patients to accurately monitor any changes in their symptoms. “

UK start-up FIKA raises £ 1.2million for workplace fitness training platform

London-based start-up FIKA has raised £ 1.2million in seed funding from lead investor Rising Stars and a syndicate of 10 expert angel investors.

FIKA’s mental health fitness platform offers employees a series of short and personalized courses, developed in partnership with performance psychologists.

The funding will be used to expand the team in all functions of the company, to drive its first go-to-market strategy and to support further R&D, in particular the development of its fitness technology, training tools. AI-based diagnostics and personalized courses.

Report reveals obsolete MRI and CT scanners in use in one-third of NHS trusts

One channel 4 Dispatches A survey reported that a third of NHS hospitals use body scanning equipment beyond the recommended lifespan of 10 years.

The use of freedom of information rules for researchers Dispatches found that 34.5% of NHS England trusts had at least one obsolete MRI machine and 27.1% of trusts had one or more obsolete CT scanners.

An NHS report released in 2020 noted that older equipment may impact patient care as it may require a 20-50% higher radiation dose to provide the same image quality and updates. software and hardware level may not be possible.

Jersey government to deploy IMS MAXIMS EPR solution

IMS MAXIMS has been selected as the preferred electronic patient record (EPR) provider to work alongside the Jersey government.

The project aims to contribute to a sustainable and continuous improvement in clinical care, to support the Jersey Care Record and to reach the maximum level of digital maturity.

Professor Enda McVeigh, Head of Clinical Information, said: “This new cloud-based EPR system will improve the efficiency and transparency of our healthcare system in Jersey. This will help deliver the ‘digital dividend’ that other business areas outside of healthcare have had, and that healthcare is now starting to experience. “

Source link

Leave a Reply

Your email address will not be published.